Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/marketing/fda-blasts-bristol-myers-over-misleading-krazati-efficacy-claims
https://www.fiercepharma.com/pharma/bms-cuts-hundreds-mirati-staffers-months-after-closing-58b-buyout
https://endpts.com/bristol-myers-gets-regulatory-clearance-to-close-mirati-deal-as-ftc-increases-pressure-on-pharma-ma/
https://www.prnewswire.com/news-releases/mirati-therapeutics-receives-positive-opinion-from-chmp-for-krazati-adagrasib-as-a-targeted-treatment-option-for-patients-with-advanced-non-small-cell-lung-cancer-nsclc-with-a-krasg12c-mutation-following-a-re-examination-proce-301984690.html
https://www.globenewswire.com//news-release/2023/11/02/2772156/35186/en/Kura-Oncology-and-Mirati-Therapeutics-Enter-into-Clinical-Collaboration-and-Supply-Agreement-to-Evaluate-KO-2806-and-Adagrasib-in-KRAS%E1%B4%B3-%E1%B6%9C-Mutated-NSCLC.html
https://www.fiercepharma.com/pharma/bristol-myers-squibbs-yearslong-courtship-mirati-revealed-securities-filing
https://ir.mirati.com/press-releases/press-release-details/2023/Mirati-Presents-Late-Breaking-Results-Evaluating-the-Combination-of-Adagrasib-and-Pembrolizumab-in-First-Line-Non-Small-Cell-Lung-Cancer-NSCLC/default.aspx
https://www.reuters.com/markets/deals/bristol-myers-squibb-acquire-mirati-48-billion-deal-2023-10-08/
https://www.fiercepharma.com/pharma/sanofi-weighs-mirati-buy-kras-cancer-drug-battle-enters-new-phase-bloomberg